Beamtherapeutics
Senior Director/Vice President, Hematology Marketing
Cambridge, MA. Posted a month ago
The role
The Senior Director/Vice President, Hematology Marketing will drive brand strategy, commercial launch readiness, and execution for Risto-cel. This person will lead the marketing and marketing operations team.
What you will do
- Develops and leads brand strategy for Risto-cel
- Ensures alignment across key cross-functional stakeholders
- Owns development of brand positioning, messaging, and competitive strategy
- Leads commercial launch readiness and execution
- Directs HCP and Patient marketing strategy
- Oversees tactical execution by agency partners and marketers
- Leads team of marketing, insights and marketing operations professionals
- Oversees generation of customer and market insights
- Leads scenario planning, risk management, and contingency strategies for launch
- Budget management
Required qualifications
- BS/BA in a relevant academic field
- Minimum 12 years business experience within the pharma/biotech/biopharma space
- Proven track record of developing and executing brand strategies in highly cross-functional environments
- Experience in cell and gene therapy is a must
- U.S. launch experience is a must
- Outstanding strategic thinking and problem-solving capabilities
- Must be capable of managing and prioritizing multiple activities
- Can operate in two worlds — big picture orientation with attention to detail
- Exceptional interpersonal skills and collaborative nature
- Demonstrated people management experience and development capabilities required
- Builds effective teams that work well across functions and groups
- Strong business and financial capabilities
Nice to have
- MBA, MD, PhD, or other graduate degree strongly preferred
- Experience in both large and small company environments a plus
About the company
Beam Therapeutics is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. The company uses base editing technology to advance a diversified portfolio of base editing programs.